Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.1150
-0.0050 (-4.17%)
Aug 15, 2025, 3:45 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 33.61 million as of August 15, 2025. Its market cap has increased by 59.72% in one year.
Market Cap
33.61M
Enterprise Value
29.43M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 33.61M, an increase of 141.66%. That is a compound annual growth rate of 10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 33.61M | 23.66% |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | 125.68M | 239.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.79B |
| Pro Medicus | 32.75B |
| Cochlear | 20.21B |
| Sonic Healthcare | 13.99B |
| Ramsay Health Care | 9.01B |
| Telix Pharmaceuticals | 5.76B |
| Ansell | 4.61B |
| Mesoblast | 3.21B |